GENERATION BIO CO. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.17 USD | +1.93% |
|
+9.31% | +92.12% |
| Apr. 12 | Transcript : Generation Bio Co. - Special Call | |
| Mar. 07 | Needham Cuts Price Target on Generation Bio to $10 From $14, Maintains Buy Rating | MT |
Presenter SpeechWhitney Ijem (Analysts)Good morning, everyone. Happy Friday. Thank you for joi...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Generation Bio Co. is a biotechnology company. The Company is innovating non-viral genetic medicines to provide durable, redosable treatments for hundreds of millions of patients living with rare and prevalent diseases. The Company is developing two distinct and complementary platforms: a potent, highly selective cell-targeted lipid nanoparticle (ctLNP) delivery system and a novel immune-quiet DNA (iqDNA) cargo produced by a scalable capsid-free manufacturing process that uses proprietary cell-free rapid enzymatic synthesis (RES). The Company is advancing a portfolio of programs guided by the potent and highly selective delivery of messenger ribonucleic acid (mRNA) and/or iqDNA using its ctLNP delivery system to target T cells, hematopoietic stem cells (HSCs), and hepatocytes, and intend to expand to additional tissues and cell types. Its work in T cells focuses on in vivo reprogramming of this cell type to treat cancer and autoimmune diseases.
Calendar
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
C
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
7
Last Close Price
3.17
USD
Average target price
7.5
USD
Spread / Average Target
+136.59%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +92.12% | 211M | |
| +8.96% | 105B | |
| -1.43% | 104B | |
| +4.40% | 22.94B | |
| -12.15% | 22.34B | |
| -4.36% | 19.25B | |
| -39.98% | 17.08B | |
| -10.04% | 16.96B | |
| +6.79% | 14.16B | |
| +38.61% | 12.63B |
- Stock Market
- Equities
- GBIO Stock
- News Generation Bio Co.
- Transcript : Generation Bio Co. - Special Call
